Zhittya Genesis Medicine is a biotechnology company based in Las Vegas, Nevada. Zhittya has been seeking to treat various vascular-diseases through the use of FGF-1, a potent growth factor capable of promoting angiogenesis and neurogenesis. Zhittya has prioritized studying Parkinson's disease after positive animal data, intranasal safety data, as well as vast public support for our efforts in Parkinson's. After our initial public presentations in 2017, Parkinson's advocates came to support us and now make up a significant portion of the over 100,000 people who receive our monthly emails.
Daniel C. Montano
Dan Montano started on the floor of the Los Angeles Stock Exchange in 1968, as a floor broker. Over the next 30 years, he managed thousands of stockbrokers as CEO of several securities firms. As an investment banker, Mr. Montano handled the IPO's of over 100 companies from 1968 until 1998. During that time, he also assisted in starting almost 100 new companies to advance new technologies. In 1998, Mr. Montano left investment banking and dedicated himself to advance biotechnology breakthroughs.
Daniel Montano secured his MBA from University of Southern California in 1974.
Dr. Jack Jacobs
President / Chief Science Officer
Dr. Jack Jacobs has been involved in the healthcare industry for over 25 years and has extensive expertise in supervising drug manufacturing operations and the design and implementation of preclinical animal trials and US FDA-authorized clinical trials. He started a new department of biological chemistry at Merck and for over 20 years worked with Mr. Montano as a chief scientific officer where Dr. Jacobs oversaw FDA-authorized clinical trials in which FGF-1 was tested in a number of medical indications, including coronary artery disease, diabetic foot ulcers, and peripheral artery disease. Dr. Jacobs received a BS degree from Davidson College and a PhD in molecular biology from Washington University, St. Louis.
Vice President of Strategic Innovations
Viktoriya (Vika) Tamlenova-Montano is vice president of strategic innovations for Zhittya Genesis Medicine Inc. For the last 20 years, she has been involved with biotechnology, handling technology transfer from the Ukrainian biotechnology companies to the USA, clinical trials, and research of new applications of angiogenesis medicines. Ms. Montano holds three Bachelor's degrees and a Master's degree from prestigious Ukrainian universities. She also speaks six languages and has been the personal translator for the first president of a free Ukraine, President Leonid M. Kravchuk. Ms. Montano has presented at universities on epigenetics, and she is dedicated to addressing women's health issues, which can be treated with angiogenesis and neurogenesis.
1120 N Town Center Dr., Summerlin, Las Vegas, Nevada.
1664 North Virginia St., Reno, Nevada
University of Nevada, Reno